EyePoint Pharmaceuticals (EYPT) Misses Q4 EPS by 6c
Tweet
Share
E-mailGet Alerts EYPT Hot Sheet
Join SI Premium – FREE
EyePoint Pharmaceuticals (NASDAQ: EYPT) reported Q4 EPS of ($0.81), $0.06 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $620 thousand versus the consensus estimate of $1.05 million.
For earnings history and earnings-related data on EyePoint Pharmaceuticals (EYPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regency Centers (REG) Tops Q2 EPS by 2c
- KKR Near Deal to Take Integer Holdings Private - WSJ
- TFS Financial (TFSL) Tops Q3 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
